Freedom Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,640
Closed -$215K 865
2021
Q3
$215K Buy
1,640
+86
+6% +$11.3K 0.02% 740
2021
Q2
$214K Buy
+1,554
New +$213K 0.02% 801
2020
Q1
Sell
-2,170
Closed -$243K 676
2019
Q4
$243K Buy
+2,170
New +$231K 0.02% 571
2018
Q4
Sell
-5,667
Closed -$459K 784
2018
Q3
$459K Buy
+5,667
New +$438K 0.03% 549
2018
Q2
Sell
-9,375
Closed -$594K 979
2018
Q1
$594K Buy
+9,375
New +$560K 0.03% 552

Other funds holding CNMD

Freedom Investment Management's CNMD Position: Q4 2021 in Review

Freedom Investment Management sold out of CONMED (CNMD) in Q4 2021, closing a stake of 1,640 shares — an estimated $215K sold.

Freedom Investment Management first reported a position in CNMD in Q1 2018 and held it in 5 quarters. The position peaked at $594K in Q1 2018. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

  • Freedom Investment Management reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
  • Freedom Investment Management sold 1,640 CONMED shares in Q4 2021, an estimated $215K.
  • Freedom Investment Management first reported a position in CONMED in Q1 2018 and held it in 5 quarters.
  • Freedom Investment Management's CONMED position peaked at $594K in Q1 2018.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on Freedom Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.